Duometacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C20H19NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L5WVJ201KN, chemically known as 1h-indole-1-acetic acid, 6-methoxy-3-(4-methoxybenzoyl)-2-methyl- but generally known as duometacin, which bears US NIH Compound Identifier 71912. European Medicines Agency schedules Duometacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06427MIG. The term DUOMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). DUOMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule duometacin under HS 29339990 and SITC 51577. As of Q4 2014, DUOMETACIN remains the US FDA Preferred Term for this commodity. Duometacin bears US NLM identifiers UMLS ID C1880428 and NCI Concept Code C65498. SMILES: O(C1CC2N(C(C(C2CC1)C(=O)C1CCC(OC)CC1)C)CC(=O)O)C.